Tiziana Life Sciences Ltd (TLSA)

NASDAQ: TLSA · IEX Real-Time Price · USD

0.666

+0.026 (4.06%)

At close: Apr 19, 2024, 3:59 PM

0.675

+0.009 (1.29%)

After-hours: Apr 19, 2024, 6:34 PM EDT

Tiziana Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	1.63	13.31	11.2	6.21	4.36	4.48	5.87
Research & Development	12.96	13.21	5.99	3.71	5.51	6.02	4.01
Other Operating Expenses	0	0.86	10.83	0	0	0	0
Operating Expenses	14.59	27.37	28.03	9.92	9.87	10.49	9.88
Operating Income	-14.59	-27.37	-28.03	-9.92	-9.87	-10.49	-9.88
Interest Expense / Income	0.01	0.18	0.31	0.09	0.01	0.01	0.01
Other Expense / Income	0.8	-0.89	-	-	-	-	-
Pretax Income	-15.4	-26.66	-28.34	-10.01	-9.88	-10.51	-9.89
Income Tax	0	-3.24	-2.21	-0.69	-1.95	-1.91	-0.12
Net Income	-15.4	-23.42	-26.13	-9.32	-7.93	-8.59	-9.77
Shares Outstanding (Basic)	102	97	68	68	70	-	-
Shares Change	5.10%	42.41%	0.14%	-2.93%	-	-	-
EPS (Basic)	-0.15	-0.24	-0.16	-0.07	-0.12	-0.18	-0.22
EPS (Diluted)	-0.15	-0.24	-0.16	-0.07	-0.12	-0.18	-0.22
Free Cash Flow	-19.62	-21.78	-11.34	-6.8	-4.6	-7.53	-6.97
Free Cash Flow Per Share	-0.19	-0.22	-0.17	-0.10	-0.07	-	-
EBITDA	-15.34	-26.34	-27.94	-9.67	-9.85	-10.48	-9.87
Depreciation & Amortization	0.05	0.14	0.09	0.25	0.02	0.01	0.01
EBIT	-15.39	-26.48	-28.03	-9.92	-9.87	-10.49	-9.88

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).